AstraZeneca is a global biopharmaceutical business that pushes the boundaries of science to deliver life-changing medicines. An agile and purposeful company that is investing over $4bn in R&D each year to pursue discoveries beyond imagination. An organisation that is active in over 100 countries, has a growing presence in emerging markets, and brings together 59,000 people in a unique spirit of innovation and collaboration.
We discover, develop, manufacture and market small molecules and biologics focused on three key areas – oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Ensuring these innovative medicines reach patients across the Globe is changing the way we think about launch and supply, driving change across our manufacturing sites and supply network.
Graduates from any discipline who are inspired by what science can do thrive in AstraZeneca’s diverse and international culture. They take real responsibility from day one, and throughout their programme they have the opportunity to contribute to ground-breaking projects and gain an extensive understanding of the global pharmaceutical industry. There has never been a more exciting time to join AstraZeneca.
We look for bright, motivated and highly driven individuals with a passion to work in pharmaceuticals and healthcare and a real desire to make a difference to patients and our business
Early Career opportunities with AstraZeneca
Operations at AstraZeneca brings innovation from our science labs to patients, touching every part of the business. As such, we have a pivotal role to play in helping our company embody its purpose and achieve its bold ambition.
In AZ IT, we are helping to push the boundaries of science to deliver life changing medicines by continuously improving our IT environment and by working closely with the business to innovate for competitive advantage.
Pharmaceutical Technology & Development (PT&D)
Pharmaceutical Technology and Development (PT&D) designs and develops the innovative products and manufacturing processes that change patients’ lives every day, from concept to commercialisation and beyond. The progress of clinical programmes, successful regulatory approvals and implementation of new manufacturing science and technology across the supply network are all dependent on the work of PT&D.
Innovative Medicines and Early Development (IMED) Biotech Unit
Each year IMED invests in excess of $1bn on discovering and developing the next generation of life changing medicines, from initial target selection through to the end of Phase two trials, and we’re focused on driving the scientific advances in small molecules, RNA and other emerging technologies and drug discovery platforms to push the boundaries of medical science.